{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T03:26:28Z","timestamp":1787196388719,"version":"build-2736575974"},"reference-count":57,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001646","name":"Robert Bosch Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2021.159.2"],"award-info":[{"award-number":["2021.159.2"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70116314, 70115054, 70112108, 70114087"],"award-info":[{"award-number":["70116314, 70115054, 70112108, 70114087"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010570","name":"Nieders\u00e4chsisches Ministerium f\u00fcr Wissenschaft und Kultur","doi-asserted-by":"publisher","award":["25 76251-12-3\/16"],"award-info":[{"award-number":["25 76251-12-3\/16"]}],"id":[{"id":"10.13039\/501100010570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ 13GW0451A+B"],"award-info":[{"award-number":["FKZ 13GW0451A+B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["393547839 \u2013 SFB 1361"],"award-info":[{"award-number":["393547839 \u2013 SFB 1361"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO-5002"],"award-info":[{"award-number":["KFO-5002"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1190 P17, BO 3643\/10-1"],"award-info":[{"award-number":["SFB1190 P17, BO 3643\/10-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2025,12,14]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The efficacy of pharmacological glycogen synthase kinase-3\u03b2 (GSK3\u03b2) inhibition is currently being investigated in unselected cohorts of metastatic pancreatic ductal adenocarcinoma (PDAC). Here, we sought to determine the clinical significance of nuclear GSK3\u03b2 accumulation in patients with resectable PDAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to explore the therapeutic potential and underlying mechanisms of GSK3\u03b2 pathway disruption in PDAC with enriched nuclear GSK3\u03b2 levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We investigated the activation and function of GSK3\u03b2 and its downstream transcription factor NFATc1 in tumour recurrence, growth and resistance using human PDAC tissues, patient-derived organoids and tumour cells, PDAC explants, cell lines and murine models. GSK3\u03b2 signalling was disrupted using genetic and pharmacological approaches. Live-cell imaging, proliferation, homologous recombination (HR) repair and comet assays, messenger RNA sequencing and chromatin immunoprecipitation were used to explore GSK3\u03b2-NFATc1 signalling-mediated target gene regulation in DNA repair, growth and resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nuclear GSK3\u03b2 accumulates in a subset of resected PDAC and promotes proliferation and DNA repair through NFATc1. The GSK3\u03b2\n                      <jats:sup>high<\/jats:sup>\n                      \/NFATc1\n                      <jats:sup>high<\/jats:sup>\n                      subtype accounts for 14% of resected PDAC and is associated with rapid tumour recurrence and poor survival. The GSK3\u03b2-NFATc1 signalling pathway contributes to cisplatin resistance by inducing BRCA genes transcription, which facilitates HR-mediated DNA double-strand breaks (DSBs) repair. Disruption of the GSK3\u03b2-NFATc1 axis impairs HR-driven DSB repair, increasing cisplatin sensitivity in vitro and in preclinical PDAC models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We have identified a highly aggressive GSK3\u03b2\n                      <jats:sup>high<\/jats:sup>\n                      \/NFATc1\n                      <jats:sup>high<\/jats:sup>\n                      subtype that predicts early recurrence, poor survival and cisplatin resistance in PDAC. This subtype reveals new treatment vulnerabilities suggesting that patients with PDAC may benefit from stratification-based tailored treatment strategies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2025-336227","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:20:12Z","timestamp":1767205212000},"page":"1520-1533","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["GSK3\u03b2\n                    <sup>high<\/sup>\n                    \/NFATc1\n                    <sup>high<\/sup>\n                    subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair"],"prefix":"10.1136","volume":"75","clinical-trial-number":[{"clinical-trial-number":"nct05077800","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05239182","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Muhammad Umair","family":"Latif","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Bockelmann","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"},{"name":"Clinical Research Unit 5002, KFO5002, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Huhnold","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geske Elisabeth","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3725-068X","authenticated-orcid":false,"given":"Lukas","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyuan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena-Christin","family":"Conradi","sequence":"additional","affiliation":[{"name":"General and Visceral Surgery, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karly","family":"Conrads","sequence":"additional","affiliation":[{"name":"Clinical Research Unit 5002, KFO5002, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"},{"name":"Department of Medical Bioinformatics, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Lena","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sercan","family":"Mercan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Reutlinger","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atmika","family":"Paul","sequence":"additional","affiliation":[{"name":"Clinical Research Unit 5002, KFO5002, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"},{"name":"Department for Molecular Oncology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynab","family":"Najafova","sequence":"additional","affiliation":[{"name":"Robert Bosch Centre for Tumour Diseases, Stuttgart, BW, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-5805","authenticated-orcid":false,"given":"Steven A","family":"Johnsen","sequence":"additional","affiliation":[{"name":"Robert Bosch Centre for Tumour Diseases, Stuttgart, BW, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuri\u00f1e","family":"Bonilla Del Rio","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike","family":"Penz","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovan","family":"Todorovic","sequence":"additional","affiliation":[{"name":"Clinical Research Unit 5002, KFO5002, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"},{"name":"Institute of Pathology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, NDS, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Bastians","sequence":"additional","affiliation":[{"name":"Department for Molecular Oncology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Beissbarth","sequence":"additional","affiliation":[{"name":"Department of Medical Bioinformatics, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Sax","sequence":"additional","affiliation":[{"name":"Clinical Research Unit 5002, KFO5002, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"},{"name":"Department of Medical Informatics, University Medical Center G\u00f6ttingen, G\u00f6ttingen, NDS, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Ashry","sequence":"additional","affiliation":[{"name":"Institute of Toxicology, University Medical Center Mainz, Mainz, Germany"},{"name":"Department of Oral Pathology, Faculty of Dentistry, Mansoura University, Mansoura, Egypt, Al-Mansura, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver H","family":"Kr\u00e4mer","sequence":"additional","affiliation":[{"name":"Institute of Toxicology, University Medical Center Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Hessmann","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"},{"name":"Clinical Research Unit 5002, KFO5002, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Schneider","sequence":"additional","affiliation":[{"name":"Clinical Research Unit 5002, KFO5002, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"},{"name":"Clinic of General, Visceral and Pediatric Surgery, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Stroebel","sequence":"additional","affiliation":[{"name":"Clinical Research Unit 5002, KFO5002, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"},{"name":"Institute of Pathology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, NDS, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Bogeski","sequence":"additional","affiliation":[{"name":"Molecular Physiology, Institute of Cardiovascular Physiology, University Medical Center G\u00f6ttingen, Gottingen, Niedersachsen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5725-4058","authenticated-orcid":false,"given":"Shiv K","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"},{"name":"Clinical Research Unit 5002, KFO5002, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9981-8571","authenticated-orcid":false,"given":"Volker","family":"Ellenrieder","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"},{"name":"Clinical Research Unit 5002, KFO5002, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"2026081901551144000_75.8.1520.1","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23237-2","article-title":"Pancreatic cancer prognosis is predicted by an ATAC-array technology for assessing chromatin accessibility","volume":"12","author":"Dhara","year":"2021","journal-title":"Nat Commun"},{"key":"2026081901551144000_75.8.1520.2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-08083-6","article-title":"Clinical features and prognostic impact of asymptomatic pancreatic cancer","volume":"12","author":"Takikawa","year":"2022","journal-title":"Sci Rep"},{"key":"2026081901551144000_75.8.1520.3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.688377","article-title":"The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy","volume":"11","author":"Principe","year":"2021","journal-title":"Front Oncol"},{"key":"2026081901551144000_75.8.1520.4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"2026081901551144000_75.8.1520.5","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v5.i2.12"},{"key":"2026081901551144000_75.8.1520.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.02.014"},{"key":"2026081901551144000_75.8.1520.7","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.695627","article-title":"Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting","volume":"11","author":"Pappalardo","year":"2021","journal-title":"Front Oncol"},{"key":"2026081901551144000_75.8.1520.8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.690056","article-title":"Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"2026081901551144000_75.8.1520.9","doi-asserted-by":"crossref","unstructured":"Luo W , Wen T , Qu X . Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept. J Exp Clin Cancer Res 2024;43. doi:10.1186\/s13046-023-02935-3","DOI":"10.1186\/s13046-023-02935-3"},{"key":"2026081901551144000_75.8.1520.10","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231171456","article-title":"The role of molecular testing in pancreatic cancer","volume":"16","author":"Zhen","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"key":"2026081901551144000_75.8.1520.11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55330-7","article-title":"Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer","volume":"16","author":"Klein","year":"2025","journal-title":"Nat Commun"},{"key":"2026081901551144000_75.8.1520.12","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16101861","article-title":"Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma","volume":"16","author":"Desai","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026081901551144000_75.8.1520.13","doi-asserted-by":"crossref","unstructured":"Fan Z , Xiao Y , Du Y , et al . Pancreatic cancer subtyping - the keystone of precision treatment. Front Immunol 2025;16. doi:10.3389\/fimmu.2025.1563725","DOI":"10.3389\/fimmu.2025.1563725"},{"key":"2026081901551144000_75.8.1520.14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.682872","article-title":"Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future Perspectives","volume":"11","author":"Miyabayashi","year":"2021","journal-title":"Front Oncol"},{"key":"2026081901551144000_75.8.1520.15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/cancers16010002","article-title":"Digging into the NGS Information from a Large-Scale South European Population with Metastatic\/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction","volume":"16","author":"Ziogas","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026081901551144000_75.8.1520.16","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0194"},{"key":"2026081901551144000_75.8.1520.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yasu.2010.05.011"},{"key":"2026081901551144000_75.8.1520.18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.seminoncol.2016.09.002","article-title":"Familial pancreatic cancer","volume":"43","author":"Petersen","year":"2016","journal-title":"Semin Oncol"},{"key":"2026081901551144000_75.8.1520.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01469-9"},{"key":"2026081901551144000_75.8.1520.20","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S211151"},{"key":"2026081901551144000_75.8.1520.21","doi-asserted-by":"crossref","unstructured":"Keane F , O\u2019Connor CA , Park W , et al . Pancreatic Cancer: BRCA Targeted Therapy and Beyond. Cancers (Basel) 2023;15. doi:10.3390\/cancers15112955","DOI":"10.3390\/cancers15112955"},{"key":"2026081901551144000_75.8.1520.22","doi-asserted-by":"crossref","unstructured":"Golan T , O\u2019Kane GM , Denroche RE , et al . Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma. Gastroenterology 2021;160. doi:10.1053\/j.gastro.2021.01.220","DOI":"10.1053\/j.gastro.2021.01.220"},{"key":"2026081901551144000_75.8.1520.23","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0309"},{"key":"2026081901551144000_75.8.1520.24","doi-asserted-by":"crossref","unstructured":"Edderkaoui M , Chheda C , Soufi B , et al . An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice. Gastroenterology 2018;155. doi:10.1053\/j.gastro.2018.08.028","DOI":"10.1053\/j.gastro.2018.08.028"},{"key":"2026081901551144000_75.8.1520.25","doi-asserted-by":"crossref","unstructured":"Park R , Coveler AL , Cavalcante L , et al . Gsk-3\u03b2 in pancreatic cancer: Spotlight on 9-ing-41, its therapeutic potential and immune modulatory properties. Biology (Basel) 2021;10. doi:10.3390\/biology10070610","DOI":"10.3390\/biology10070610"},{"key":"2026081901551144000_75.8.1520.26","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1002\/cncr.35031","article-title":"Top advances of the year: Pancreatic cancer","volume":"129","author":"Warren","year":"2023","journal-title":"Cancer"},{"key":"2026081901551144000_75.8.1520.27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0799"},{"key":"2026081901551144000_75.8.1520.28","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.853003","article-title":"Nuclear GSK-3\u03b2 and Oncogenic KRas Lead to the Retention of Pancreatic Ductal Progenitor Cells Phenotypically Similar to Those Seen in IPMN","volume":"10","author":"Ding","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"2026081901551144000_75.8.1520.29","unstructured":"Fernandez-Zapico ME , Savoy DN , Urrutia RA , et al . Glycogen synthase kinase-3b participates in nuclear factor kb-mediated gene transcription and cell survival in pancreatic cancer cells. n.d. Available: http:\/\/cancerres.aacrjournals.org\/"},{"key":"2026081901551144000_75.8.1520.30","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.90"},{"key":"2026081901551144000_75.8.1520.31","first-page":"147","article-title":"Glycogen Synthase Kinase 3\u03b2 in Pancreatic Cancer and its Implications in Chemotherapy and Radiation Therapy","volume":"4","author":"Zhang","year":"2013","journal-title":"J Carcinog Mutagen"},{"key":"2026081901551144000_75.8.1520.32","first-page":"5","article-title":"The role of glycogen synthase kinase 3 (GSK3) in cancer with emphasis on ovarian cancer development and progression: A comprehensive review","volume":"21","author":"Glibo","year":"2021","journal-title":"Bosn J Basic Med Sci"},{"key":"2026081901551144000_75.8.1520.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.11.016"},{"key":"2026081901551144000_75.8.1520.34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.813527"},{"key":"2026081901551144000_75.8.1520.35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.197533"},{"key":"2026081901551144000_75.8.1520.36","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920947970","article-title":"FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules","volume":"12","author":"Foschini","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"2026081901551144000_75.8.1520.37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08290-2","article-title":"Differential damage and repair of DNA-adducts induced by anti-cancer drug cisplatin across mouse organs","volume":"10","author":"Yimit","year":"2019","journal-title":"Nat Commun"},{"key":"2026081901551144000_75.8.1520.38","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/201367"},{"key":"2026081901551144000_75.8.1520.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.07.025"},{"key":"2026081901551144000_75.8.1520.40","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319984"},{"key":"2026081901551144000_75.8.1520.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2014.03.014"},{"key":"2026081901551144000_75.8.1520.42","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2008.1"},{"key":"2026081901551144000_75.8.1520.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.12.009"},{"key":"2026081901551144000_75.8.1520.44","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201489574"},{"key":"2026081901551144000_75.8.1520.45","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102711","article-title":"Generation and ex vivo culture of murine and human pancreatic ductal adenocarcinoma tissue slice explants","volume":"4","author":"Decker-Farrell","year":"2023","journal-title":"STAR Protoc"},{"key":"2026081901551144000_75.8.1520.46","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1369136","article-title":"Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies","volume":"11","author":"Linehan","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"2026081901551144000_75.8.1520.47","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00780-4","article-title":"KRAS mutation: from undruggable to druggable in cancer","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2026081901551144000_75.8.1520.48","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-1066"},{"key":"2026081901551144000_75.8.1520.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.02.012"},{"key":"2026081901551144000_75.8.1520.50","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30856-3"},{"key":"2026081901551144000_75.8.1520.51","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-03475-4","article-title":"Glycogen synthase kinase 3\u03b2 inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"key":"2026081901551144000_75.8.1520.52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jbior.2017.05.001","article-title":"GSK-3 as a novel prognostic indicator in leukemia","volume":"65","author":"Ruvolo","year":"2017","journal-title":"Adv Biol Regul"},{"key":"2026081901551144000_75.8.1520.53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbacli.2015.07.001","article-title":"Phosphorylation of GSK3\u03b1\/\u03b2 correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients","volume":"4","author":"Ruvolo","year":"2015","journal-title":"BBA Clin"},{"key":"2026081901551144000_75.8.1520.54","doi-asserted-by":"crossref","first-page":"118738","DOI":"10.1016\/j.bbamcr.2020.118738","article-title":"The cross-talk of NOTCH and GSK-3 signaling in colon and other cancers","volume":"1867","author":"Bertrand","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2026081901551144000_75.8.1520.55","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1053\/j.gastro.2023.10.026","article-title":"An NFATc1\/SMAD3\/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies","volume":"166","author":"Hasselluhn","year":"2024","journal-title":"Gastroenterology"},{"key":"2026081901551144000_75.8.1520.56","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325013"},{"key":"2026081901551144000_75.8.1520.57","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2735"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-336227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T03:06:30Z","timestamp":1787195190000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-336227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":57,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,7,8]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/gutjnl-2025-336227"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-336227","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}